Phase I Trial of 4'-Thio-2'-Deoxycytidine (TdCyd) in Patients With Advanced Solid Tumors
Clinical trial NCT02423057 · COMPLETED
Trial details
- NCT number
- NCT02423057
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-18
- Primary completion
- 2019-03-19
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.